Liver metastases from colorectal cancer: Drug delivery with liposome- encapsulated doxorubicin

Radiology

Volumn 205, Issue 1, 1997, Pages 95-101

  Cay, Osman ^a   Kruskal, Jonathan B ^a   Nasser, Imad ^a   Thomas, Peter ^a   Clouse, Melvin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Liposomes; Liver neoplasms, chemotherapeutic infusion; Liver neoplasms, secondary

Indexed keywords

DOXORUBICIN; FLUORESCEIN; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; HEPATIC ARTERY; HUMAN; HUMAN CELL; HYPOXIA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIVER METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PORTAL VEIN; PRIORITY JOURNAL;

EID: 0030819046     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.205.1.9314969     Document Type: Article

References (36)

1. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13:238-252.
2. Sugerman MS, Perez-Soler R. Liposomes in the treatment of malignancy: a clinical perspective. Crit Rev Oncol Hematol 1992; 12:231-242.
3. Weinstein JN, Leserman LD. Liposomes as drug carriers in cancer therapy. Pharmacol Ther 1984; 24:207-233.
4. Vaage J, Mayhew E. Immunotherapy of a mouse mammary carcinoma by sustained release of IL-2. Int J Cancer 1991; 47:582-585.
5. Unger E, Cardenas D, Zerella A, Fajardo LL, Tilcock C. Biodistribution and clearance of liposomal gadolinium-DTPA. Invest Radiol 1990; 25:638-644.
6. Ostro MJ, Cullis PR. Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm 1989; 46:1576-1587.
7. Kim S. Liposomes as carriers of cancer chemotherapy: current status and future prospects. Drugs 1993; 46:618-638.
8. Wright KC, Kasi LP, Jahns MS, Hashimoto S, Wallace S. Liposome distribution after intravenous and selective intraarterial infusion in dogs. Radiology 1990; 176:691-694.
9. Hwang KJ, Luk KK, Beaumier PL. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. Proc Natl Acad Sci USA 1980; 77:4030-4034.
10. Gabizon A, Chisin R, Amselem S, et al. Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer 1991; 64:1125-1132.
11. Papahadjopoulos D, Gabizon A. Targeting of liposomes to tumor cells in vivo. Ann NY Acad Sci 1983; 507:64-74.
12. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 1988; 85: 6949-6953.
13. Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1991; 1070:187-192.
14. Mayhew EG, Lasic D, Babbar S, Martin FJ. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int J Cancer 1992; 51:302-309.
15. Allen TM. Stealth liposomes: avoiding reticuloendothelial uptake. In: Lopez-Berestein G, Fidler IJ, eds. Liposomes in the therapy of infectious diseases and cancer. New York, NY: Liss, 1989; 405-415.
16. Papahadjopoulos D, Allen D, Gabizon A, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor efficacy. Proc Natl Acad Sci USA 1991; 88:11460-11464.
17. Working PK, Newman MS, Huang SK, et al. Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in stealth liposomes (DOXIL). J Lipid Res 1994; 4:667-687.
18. Huang SK, Martin FJ, Jay G, Vogel J, Papahadjopoulos D, Friend DS. Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV TAT gene. Am J Pathol 1993; 143:10-14.
19. Vaage J, Barbera-Guillem E, Abra R, Huang A, Working P. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer 1994; 73:1478-1483.
20. Vaage J, Donovan D, Mayhew E, Abra R, Huang A. Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. Cancer 1993; 72:3671-3675.
21. Gabizon A, Shiota R, Papahadjopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulating times. J Natl Cancer Inst 1989; 81:1484-1488.
22. Cay O, Kruskal J, Thomas P, Clouse ME. Targeting of different ethiodized oil-doxorubicin mixtures to hypovascular hepatic metastases with intraarterial and intraportal injections. JVIR 1996; 7:409-417.
23. Zuo Y, Horikoshi I, Kasagi T, Gu X, Perez-Soler R. Organ distribution and antitumor activity of free and liposomal doxorubicin injected into the hepatic artery. Cancer Chemother Pharmacol 1993; 31:313-318.
24. Zuo Y, Horikoshi I, Ueno M, Gu X, Perez-Soler R. Targeting liver tumors by administering liposomal doxorubicin into hepatic artery. Int J Cancer 1992; 51:232-237.
25. Konno H, Maruo Y, Matsuda I, Nakamura S, Baba S. Intra-arterial liposomal adriamycin for metastatic adenocarcinoma of the liver. Eur Surg Res 1995; 27:301-306.
26. Kruskal JB, Hlatky L, Hahnfeldt P, Teramoto K, Stokes KS, Clouse ME. In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver rumors. JVIR 1993; 4:741-747.
27. Cay O, Radnell O, Jeppsson B, Ahren B, Bengmark S. Inhibitory effect of 2-deoxy-D-glucose on liver tumor growth in rats. Cancer Res 1992; 52:5794-5796.
28. Clouse ME, Perry L, Stuart K, Stokes KR. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 1994; 55(suppl 3):92-97.
29. Clouse ME, Stokes KR, Kruskal JB, et al. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder. JVIR 1993; 4:717-725.
30. Kobayashi H, Inoue H, Shinohara S, et al. Intra-arterial injection of adriamycin/mitomycin C Lipiodol suspension in liver mé tastases. Acta Radiol 1987; 28:275-280.
31. Soulen MC. Chemoembolization of hepatic malignancies. Oncology 1994; 8:77-84.
32. Borener M, Castiglione M, Triller J, et al. Considerable side effects of chemoembolization for colorectal carcinoma metastatic to the liver. Ann Oncol 1992; 3:113-115.
33. Ackerman NB, Sien WM, Silverman NA. The blood supply of experimental liver metastases. Surgery 1972; 71:636-641.
34. Kan Z, Ivancev K, Lunderquist A. Peribiliary plexa: important pathways for shunting of iodized oil and silicon rubber solution from the hepatic artery to the portal vein. Invest Radiol 1994; 29:671-676.
35. Leunig M, Yuan F, Menger MD, et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 1992; 52:6553-6560.
36. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-593.